You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MLYS Exercise Disclosure
Rodman David Malcom · SEC Form 4 · Filed Jul 20, 2026
Exercise
Calculated transaction value
$6.42K
Rodman David Malcom Chief Medical Officer
MLYS
Transaction date
Jul 17, 2026
Public filing date
Jul 20, 2026
Filing lag
Filed 3 days later
MLYS daily price context
Close on/before transaction
$27.09
Jul 17, 2026
First close after public filing
$27.52
Jul 21, 2026
30-day return after filing
-2.07%
Through Aug 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 416 shares @ $15.44
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001672659-26-000036
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$17.46K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mineralys Therapeutics, Inc. MLYS | Sale | Jul 17, 2026 | $11.04K |
| Mineralys Therapeutics, Inc. MLYS Current | Exercise | Jul 17, 2026 | $6.42K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jul 17, 2026 | $0 |